Development, sales, and customer support for KIBIT solutions

「This tool began being offered in October 2025 as an ancillary service of Nippon Life Insurance Company's Nissay Mirai no Katachi Dementia Insurance (Dementia Support Plus), and has been implemented in society in coordination with Nissay Information Technology Co., Ltd.'s Kurashi no Nōtore. In March 2026, we also announced our participation in Asahi Life Insurance Company's Minna no Anshin 100-Year Project, with plans to begin offering the service within the ecosystem being built by the project.」

「We jointly developed Talk Lab KIBIT, a conversational web application service that uses AI analysis to assess cognitive health, with Shionogi & Co., Ltd., and began offering it on 1 October 2025.」

「We provide routine compliance audit solutions centered on KIBIT Eye and KIBIT Knowledge Probe. Through activities focused on expanding business with major customers, we aim to stabilize the earnings base of our group and achieve sustained growth by further expanding recurring revenue.」

「During the interim consolidated period, Mitsubishi Electric Corporation announced the implementation of KIBIT Eye to prevent confidential information leaks using AI, as part of its data-driven risk control strategy.」

「During the consolidated fiscal year, revenue from this field accumulated to approximately 60%, making a significant contribution to stabilizing and steadily expanding the earnings base of our group.」

「We obtained a patent for technology used in KIBIT Eye, a fraud detection system announced in March 2023. Based on this patented technology, we have implemented basic functions required for auditing, including display functions such as scoring and highlighting of KIBIT Eye's analysis results and retraining of the training data used in standard functions.」

「Demand for investment, particularly to address compliance requirements, remains high. KIBIT Eye, a fraud detection system announced in March 2023, continued to contribute to consolidated revenue following the consolidated first quarter, and discussions with several companies regarding implementation are ongoing. Product development is also progressing steadily, including the development and enhancement of products such as KIBIT WordSonar for VoiceView and KIBIT WordSonar for AccidentView.」

「KIBIT Eye, a routine audit system announced in March 2023, continued to contribute to consolidated revenue during the cumulative first-quarter period, and discussions with several companies regarding implementation are ongoing.」

「During the consolidated fourth quarter, we announced KIBIT Eye, a routine audit system equipped with a new AI engine.」

「In the business intelligence field, KIBIT Communication Meter was adopted by several companies in response to demand for corporate digital transformation, resulting in revenue of ¥1,056.056 million, up 18.3% year on year. However, the number of large projects driving performance was limited, and revenue fell short of the forecast.」

「Against this backdrop, orders for KIBIT Communication Meter, an email and chat audit system, increased as several companies recognized the strengths of our AI technology in objectivity and analysis. In April 2022, we also began offering WordSonar for VoiceView, which analyzes the voice of customers at financial institutions to detect early signs of misconduct and improve customer loyalty.」

「We raised awareness and built up our pipeline through sales of Mekiki, an AI system that automatically classifies medical and specialized medical information, and the adoption of Amanogawa, an AI system for searching research papers, by hospitals as well as pharmaceutical companies.」

「In the Medical Intelligence field, we further expanded the scope of application. On 3 August 2021, we began offering Mekiki, automated classification AI software that uses artificial intelligence (AI) to classify specialized medical information, and continued developing WordATLAS, an AI system that analyzes medical papers and supports pharmaceutical companies in formulating information strategies.」

「On 31 May 2021, we announced the launch of Kizashi KIBIT, which supports the reduction of disaster risks at construction sites and is based on a hazard prediction system developed with the cooperation of Sumitomo Mitsui Construction Co., Ltd.」

「In other fields, we developed Takumi KIBIT, a system that accumulates and passes on the knowledge of skilled technicians accumulated in manufacturing plants as organizational knowledge, as well as a product that uses AI to support hazard prediction activities at construction sites. We have begun sales activities to provide our AI products to a broader range of industries.」

「This will enable us to independently handle and provide the full range of activities for AI medical devices, from technology development through product, clinical and manufacturing development and sales.」

「We continued discussions with Microsoft Japan on collaboration to provide solutions addressing healthcare and caregiving risks associated with population aging (announced in October 2020). We first plan to develop a dementia diagnosis support AI system on Microsoft Japan's cloud platform and are considering providing a drug discovery support AI system on the platform in the future.」

「In digital health, we moved forward toward approval and commercialization of this system as an AI medical device by entering into a development and sales partnership agreement with Kyowa Pharmaceutical Co., Ltd. in June 2020 for a dementia diagnosis support AI system (medical device).」

「In the life sciences AI field, we built a foundation for future growth in drug discovery using the Concept Encoder artificial intelligence (AI) engine and in digital health, where AI is being applied to clinical care, diagnosis, nursing and caregiving support.」

「In particular, in the life sciences AI field, we announced a joint research project with Takeda Pharmaceutical Company Limited and Iwate Medical University to study the diagnosis and treatment of Parkinson's disease using AI and genomics. Analysis using the Concept Encoder artificial intelligence (AI) engine revealed important fundamental information related to the diagnosis of Parkinson's disease, and we will continue advancing the research toward personalized medicine tailored to each patient.」

「Against this backdrop, we began offering pharmaceutical companies an MR (medical representative) daily and weekly report review solution powered by our proprietary AI engine, KIBIT.」

「In healthcare, we also began offering a drug discovery research support AI system powered by Concept Encoder, a new artificial intelligence (AI) engine combining objectivity, transparency and reproducibility. Concept Encoder is hereafter referred to as CE.」

「During the consolidated fiscal year, we developed the second-generation KIBIT, KIBIT G2, which enables integration with customer systems and third-party systems.」

「In the healthcare field, we began providing pharmaceutical companies with a technology for searching for novel drug candidates using the new artificial intelligence (AI) engine Concept Encoder, which combines objectivity, transparency and reproducibility.」

「In the stock-based AI Solutions business, the number of companies adopting KIBIT products reached 121. In addition, in the business intelligence field, we were selected for the Patent Office's public project, Efficiency Improvements in the Examination of Trademark Registration Applications Using Artificial Intelligence, for the second consecutive year in the second quarter.」

「In the first quarter, we were selected for the Financial Services Agency's FinTech Demonstration Experiment Hub for the first time as an AI project, and on 1 August 2018 we announced that the use of KIBIT in record-checking operations at financial institutions had substantially improved operational productivity. We also released a new product, KIBIT Find Answer, as a support tool for inquiry-handling operations, for which demand is high across a range of industries and business fields.」

「As a major achievement during the consolidated fiscal year, our Group developed its second proprietary artificial intelligence (AI) engine, Concept Encoder.」

「In the healthcare field, we established an integrated structure covering research and development, analysis and sales based on an evidence-based approach. As a result of strengthening the organisation, we can now respond to the specific needs of the healthcare sector with higher quality and speed. In the third quarter, we won 3 new orders from the pharmaceutical industry, and development of several medium-term projects, including the Fall and Drop Prediction System, the Pain Care Support AI System and the Objective Evaluation Device for Mental Disorders, progressed smoothly.」

「In the digital communications field, we are developing new areas in which KIBIT can be used in the B2B2C sector. For Kibiro, an artificial-intelligence-equipped robot, we began offering a new package, Kibiro for Biz, with additional functions in demand among corporate customers, while also developing a monitoring function for the consumer model.」

「In the digital communications field, we launched a reception service for Kibiro, an artificial-intelligence-equipped robot, jointly developed with 株式会社オフィス２４. Going forward, we plan to jointly develop with customer companies services for a range of industries, including concierge services for hotels and counselling services for beauty and esthetic salons.」

「In the fourth quarter of the consolidated fiscal year, we also began selling Kibiro, a robot equipped with artificial intelligence. In addition to sales to general consumers, we are pursuing partnerships with companies, increasing opportunities for media exposure.」

「To broaden the user base, in November 2016 we began providing the AI Expert Training Course and AI Process Outsourcing. In the healthcare field, the beta version of the Fall and Drop Prediction System being jointly researched and developed with NTT East Kanto Hospital was completed in December 2016.」

「In the healthcare field, in October 2016 we entered into an agreement to begin discussions on joint research with the Public Interest Incorporated Foundation Cancer Institute and began developing a personalised cancer care AI system that uses the KIBIT artificial intelligence engine to enable anyone to retrieve the latest and most appropriate information. In the digital marketing field, in October 2016 we began providing a vehicle-model recommendation service using our artificial intelligence through 株式会社IDOM's online customer service, Car Connect, formerly operated by 株式会社ガリバーインターナショナル. In November 2016, we also began advance sales to general consumers of Kibiro, a robot equipped with the KIBIT artificial intelligence engine. In the business intelligence field, customer adoption progressed steadily for Lit i View AI助太刀侍, a business data analysis system designed to support corporate business strategies, and Lit i View PATENT EXPLORER, an intellectual property strategy support system designed to analyse extensive patent-related information, driving growth in the AI business.」

「In the healthcare field, development of a fall prediction system being undertaken jointly with NTT East Kanto Hospital is progressing toward completion. Meanwhile, in June we began joint research with Rakuwakai Healthcare System and 株式会社フォーカスシステムズ on the use of artificial intelligence in medical businesses, including decision-making and decision support related to hospital management and the operation of medical facilities. In the digital marketing field, we began joint development with 株式会社IDOM, formerly 株式会社ガリバーインターナショナル, to use our artificial intelligence in IDOM's online customer service, Car Connect, to provide automated customer service support, with service provision targeted for September 2016.」

「Our Group is expanding solutions in 3 fields, healthcare, digital marketing and business intelligence, using its proprietary artificial intelligence technology, KIBIT. We will continue to promote product development and service provision in each of these fields.」